Panthera Expands Glasgow Clinical Research Operations with Move to Health Innovation Hub (HiH)
Panthera, the UK’s largest independent Site Management Organisation (SMO) specialising in patient recruitment and clinical trial management for global pharmaceutical companies, has relocated its Glasgow Clinical Research site from the Clinical Innovation Zone (CIZ) at Queen Elizabeth University Hospital to the prestigious Health Innovation Hub (HiH) in the Glasgow Riverside Innovation District (GRID).
The state-of-the-art facility, which opened to patients last week, features eight bespoke clinical rooms, laboratory facilities, and modern office space. Patients who attend will benefit from a spacious waiting area and a café. There are excellent parking facilities and public transport links, including bus and train, ensuring easy access to the site.
The move to the HiH will allow Panthera – which currently has six sites across the UK and is expanding into Europe – to expand its operations, increase capacity and offer further opportunities for people in Glasgow to take part in clinical research.
Stuart Young, CEO at Panthera, commented, “We are delighted to be moving into this new centre of excellence as we expand to meet the growing demand from our sponsors and patients. More people in Glasgow will now have the chance to participate in clinical trials, gaining early access to cutting-edge treatments for life-changing conditions well before they become widely available through the NHS.”
HiH is Glasgow’s new purpose-built life science facility, which was opened last month by Wes Streeting, UK Secretary of State for Health and Social Care. The centre is at the forefront of R&D on the development of precision medicine technologies ahead of commercialisation. This flagship investment is being delivered and operated by Kadans Science Partner, in collaboration with The Living Laboratory for Precision Medicine, a University of Glasgow-led programme.. Further cementing Glasgow as a leader in the science sector.